The University of Rochester Medical Center (URMC) has resumed all surgeries, including elective procedures, following delays ...

Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

According to FDA, Hurricane Helen caused a supply disruption of IV solutions from Baxter’s facility in North Carolina.

ICU Medical (ICUI) and Otsuka are launching a joint venture focused on boosting IV solutions production and development in North America. Read more here.

Doctors say they've been forced to ration care as sourcing the essential medicine continues to prove a challenge.

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...

Recent quality and operational issues at Smiths, which originated before it was purchased, greatly reduced ICU’s gross margin after the acquisition. These issues have required additional spending to ...

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.